 |
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
Promimic AB Promimic is a biomaterial company that develops and markets a unique implant surface that dramatically accelerates osseointegration, as well as future solutions for synthetic bone grafts. The innovation is based on modern nano technology developed by researchers from Chalmers University of Technology.Promimic specializes in the production of the bioactive substance hydroxyapatite, which mimics human bone tissue, through size, shape, structure and chemistry. This patented innovation can be used for several applications in the medtech and biotech industry. Promimic’s customers are found in the implant and biosensor industries. The business model for the first line of products is based on licensing. Contact Ulf Brogren, CEO 
 +46 31 772 80 22
 www.promimic.se
|
|
|
||||||||||||||||||||||||||||||||||||||||||
